BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23118218)

  • 1. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
    Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
    Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD74 is dispensable for development of chronic lymphocytic leukemia in
    Barthel R; Fedorchenko O; Velmans T; Rosen N; Nguyen PH; Reinart N; Florin A; Herling M; Hallek M; Fingerle-Rowson G
    Leuk Lymphoma; 2020 Dec; 61(12):2799-2810. PubMed ID: 32667245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.
    Das R; LaRose MI; Hergott CB; Leng L; Bucala R; Weiser JN
    J Immunol; 2014 Jul; 193(2):764-72. PubMed ID: 24928996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite.
    Filbey KJ; Varyani F; Harcus Y; Hewitson JP; Smyth DJ; McSorley HJ; Ivens A; Nylén S; Rottenberg M; Löser S; Maizels RM
    Front Immunol; 2019; 10():2375. PubMed ID: 31708913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia.
    Thavayogarajah T; Sinitski D; El Bounkari O; Torres-Garcia L; Lewinsky H; Harjung A; Chen HR; Panse J; Vankann L; Shachar I; Bernhagen J; Koschmieder S
    Exp Hematol; 2022 Nov; 115():30-43. PubMed ID: 36096455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBET-expressing Th1 CD4
    Roessner PM; Hanna BS; Öztürk S; Schulz R; Llaó Cid L; Yazdanparast H; Scheffold A; Colomer D; Stilgenbauer S; Lichter P; Seiffert M
    Br J Haematol; 2020 Apr; 189(1):133-145. PubMed ID: 31724172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.
    Patrussi L; Capitani N; Ulivieri C; Manganaro N; Granai M; Cattaneo F; Kabanova A; Mundo L; Gobessi S; Frezzato F; Visentin A; Finetti F; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Leoncini L; Efremov DG; Baldari CT
    Haematologica; 2019 Oct; 104(10):2040-2052. PubMed ID: 30819907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
    Greene JT; Mani R; Ramaswamy R; Frissora F; Yano M; Zapolnik K; Harrington B; Wasmuth R; Tran M; Mo X; McKenna M; Rangnekar VM; Byrd JC; Bondada S; Muthusamy N
    Blood Adv; 2019 Apr; 3(8):1255-1266. PubMed ID: 30987970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
    Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
    Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Macrophage and Dendritic Cell Response in
    Sánchez-Zamora YI; Juarez-Avelar I; Vazquez-Mendoza A; Hiriart M; Rodriguez-Sosa M
    J Diabetes Res; 2016; 2016():7053963. PubMed ID: 27699180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
    Stojanovic I; Mirkov I; Kataranovski M; Glamoclija J; Stosic-Grujicic S
    Immunobiology; 2011 Sep; 216(9):1018-27. PubMed ID: 21489649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation.
    Yoshihisa Y; Makino T; Matsunaga K; Honda A; Norisugi O; Abe R; Shimizu H; Shimizu T
    J Invest Dermatol; 2011 Apr; 131(4):925-31. PubMed ID: 21191413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.
    Grioni M; Brevi A; Cattaneo E; Rovida A; Bordini J; Bertilaccio MTS; Ponzoni M; Casorati G; Dellabona P; Ghia P; Bellone M; Calcinotto A
    Blood Adv; 2021 Jul; 5(14):2817-2828. PubMed ID: 34269799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction.
    Paiva CN; Arras RH; Magalhães ES; Alves LS; Lessa LP; Silva MH; Ejzemberg R; Canetti C; Bozza MT
    J Leukoc Biol; 2009 May; 85(5):855-61. PubMed ID: 19188484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
    Dong S; Harrington BK; Hu EY; Greene JT; Lehman AM; Tran M; Wasmuth RL; Long M; Muthusamy N; Brown JR; Johnson AJ; Byrd JC
    J Clin Invest; 2019 Jan; 129(1):122-136. PubMed ID: 30457982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of macrophage migration inhibitory factor in corneal neovascularization.
    Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.
    Prieto-Lafuente L; Gregory WF; Allen JE; Maizels RM
    J Leukoc Biol; 2009 May; 85(5):844-54. PubMed ID: 19179453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.